ConductScience.org, home

Paper5334595

Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers.

Smith CB and 2 others. JAMA, 1967. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers. Papers, record 5334595. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5334595

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers.
PubMed
Journal
JAMA
PubMed
Year
1967
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
76
iCite
Revised in PubMed
2016-10-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith CBC B
2Friedewald WTW T
3Chanock RMR M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibody FormationMajor topic
Bacterial VaccinesMajor topic
MycoplasmaMajor topic
PneumoniaMajor topic
Adult
Clinical Trials as Topic
Erythromycin
Evaluation Studies as Topic
Humans
Male
Placebos
Respiratory Tract Diseases
Tetracycline

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
41438744Development of human mycoplasma vaccines: navigating the IL-17A paradox.Front Immunol2025https://conductscience.org/library/papers/41438744PubMed
41012172Adjuvant Mucosal Strategies Confer Safe and Effective Immunity Against Mycoplasma pneumoniae and Overcome Vaccine-Associated Enhanced Lung Pathology.Vaccines (Basel)2025https://conductscience.org/library/papers/41012172PubMed
40650312An mRNA Vaccine Targeting the C-Terminal Region of P1 Protein Induces an Immune Response and Protects Against Mycoplasma pneumoniae.Int J Mol Sci2025https://conductscience.org/library/papers/40650312PubMed
39291404Research of recombinant influenza A virus as a vector for Mycoplasma pneumoniae P1a and P30a.Immun Inflamm Dis2024https://conductscience.org/library/papers/39291404PubMed
36310317B cells oppose Mycoplasma pneumoniae vaccine enhanced disease and limit bacterial colonization of the lungs.NPJ Vaccines2022https://conductscience.org/library/papers/36310317PubMed
35906257Vaccination with Mycoplasma pneumoniae membrane lipoproteins induces IL-17A driven neutrophilia that mediates Vaccine-Enhanced Disease.NPJ Vaccines2022https://conductscience.org/library/papers/35906257PubMed
34481867SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.Biochim Biophys Acta Mol Basis Dis2021https://conductscience.org/library/papers/34481867PubMed
33503845Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development.Pathogens2021https://conductscience.org/library/papers/33503845PubMed
33195997Applying Immune Instincts and Maternal Intelligence from Comparative Microbiology to COVID-19.SN Compr Clin Med2020https://conductscience.org/library/papers/33195997PubMed
32285942Defining protective epitopes for COVID-19 vaccination models.J Med Virol2020https://conductscience.org/library/papers/32285942PubMed
32284882Lipid moieties of Mycoplasma pneumoniae lipoproteins are the causative factor of vaccine-enhanced disease.NPJ Vaccines2020https://conductscience.org/library/papers/32284882PubMed
30396892Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae.Infect Immun2019https://conductscience.org/library/papers/30396892PubMed
23001692Mycoplasma pneumoniae extract induces an IL-17-associated inflammatory reaction in murine lung: implication for mycoplasmal pneumonia.Inflammation2013https://conductscience.org/library/papers/23001692PubMed
22252865Vaccination of BALB/c mice with an avirulent Mycoplasma pneumoniae P30 mutant results in disease exacerbation upon challenge with a virulent strain.Infect Immun2012https://conductscience.org/library/papers/22252865PubMed
16557776Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease.Infect Immun1970https://conductscience.org/library/papers/16557776PubMed
10341174Respiratory diseases among U.S. military personnel: countering emerging threats.Emerg Infect Dis1999https://conductscience.org/library/papers/10341174PubMed
8244491Mycoplasma infections of the human respiratory tract.Indian J Pediatr1993https://conductscience.org/library/papers/8244491PubMed
8112834Immunoblot analyses of chimpanzee sera after infection and after immunization and challenge with Mycoplasma pneumoniae.Infect Immun1994https://conductscience.org/library/papers/8112834PubMed
6779413Exfoliation of respiratory epithelium in hamster tracheal organ cultures infected with Mycoplasma pneumoniae.Virchows Arch A Pathol Anat Histol1980https://conductscience.org/library/papers/6779413PubMed
5359607Characteristics of virulent, attenuated, and avirulent Mycoplasma pneumoniae strains.J Bacteriol1969https://conductscience.org/library/papers/5359607PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5334595

GET https://conductscience.org/api/papers/v1/5334595/cited_by?page=2